Zimbabwe will begin rolling out lenacapavir, a twice-yearly HIV prevention drug with 99% efficacy, prioritizing mothers and newborns as part of a …
Zimbabwe will begin rolling out lenacapavir, a twice-yearly HIV prevention drug with 99% efficacy, prioritizing mothers and newborns as part of a …
The Zimbabwe Advocate is more than just a news outlet. We are a movement, a symbol of resistance against misinformation.
© 2025 The Zimbabwe Advocate. All Rights Reserved.